Zimmer Biomet (ZBH) Acquires Monogram Technologies to Expand AI-Driven Orthopedic Robotics Portfolio

Zimmer Biomet Holdings Inc. (NYSE:ZBH) ranks among the best medical device stocks to invest in. Zimmer Biomet Holdings Inc. (NYSE:ZBH) announced on October 7 that it successfully acquired Monogram Technologies Inc., an AI-driven orthopedic robotics firm, for an upfront payment of about $177 million. This expands Zimmer Biomet’s orthopedic solution range by integrating Monogram’s semi-autonomous and fully autonomous robotic technology.

Source: Pixabay

Zimmer Biomet’s technology portfolio already includes its ROSA Robotics platform with almost 2,000 installations globally. According to the company, it is still dedicated to developing the platform, even after the Monogram acquisition. A number of new products, including the ROSA Knee with OptimiZe, which is pending FDA approval, are expected between this year and 2027.

Zimmer Biomet Holdings Inc. (NYSE:ZBH) is a global medical technology company that designs, develops, manufactures, and markets orthopaedic products, including implants, digital and robotic solutions.

While we acknowledge the potential of ZBH to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than ZBH and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 10 Best Magic Formula Stocks for 2025 and 10 Best Retirement Stocks to Buy According to Hedge Funds.

Disclosure: None. This article is originally published at Insider Monkey.